30.01
price down icon1.19%   -0.36
after-market Handel nachbörslich: 30.59 0.58 +1.93%
loading

Edgewise Therapeutics Inc Aktie (EWTX) Neueste Nachrichten

pulisher
Feb 13, 2026

Edgewise Therapeutics Teases Phase 3 Sevasemten Readout, HCM Data Update at Guggenheim Conference - MarketBeat

Feb 13, 2026
pulisher
Feb 13, 2026

(EWTX) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Feb 13, 2026
pulisher
Feb 13, 2026

Will Edgewise Therapeutics Inc. stock gain from government policiesJuly 2025 EndofMonth & AI Forecast Swing Trade Picks - mfd.ru

Feb 13, 2026
pulisher
Feb 12, 2026

Is Edgewise Therapeutics Inc. stock positioned for long term growthJuly 2025 Review & Low Risk High Reward Trade Ideas - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

EWTX: Phase III readouts and new cardiac programs drive momentum, with strong commercial readiness - TradingView

Feb 12, 2026
pulisher
Feb 12, 2026

Can Edgewise Therapeutics Inc. reach all time highs this yearJuly 2025 Rallies & Free Accurate Trade Setup Notifications - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

Assessing Edgewise Therapeutics (EWTX) Valuation After Recent Share Price Momentum - Yahoo Finance

Feb 12, 2026
pulisher
Feb 12, 2026

Is Edgewise Therapeutics Inc. subject to activist investor interestJuly 2025 WrapUp & Low Drawdown Trading Techniques - mfd.ru

Feb 12, 2026
pulisher
Feb 11, 2026

Published on: 2026-02-11 09:46:19 - mfd.ru

Feb 11, 2026
pulisher
Feb 11, 2026

Why Edgewise Therapeutics Inc. stock remains on watchlistsSwing Trade & Daily Technical Forecast Reports - mfd.ru

Feb 11, 2026
pulisher
Feb 10, 2026

Piper Sandler Sticks to Their Buy Rating for Edgewise Therapeutics (EWTX) - The Globe and Mail

Feb 10, 2026
pulisher
Feb 10, 2026

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: A Biotech Gem with 26% Upside Potential - DirectorsTalk Interviews

Feb 10, 2026
pulisher
Feb 10, 2026

Edgewise Therapeutics stock hits 52-week high at $30.26 By Investing.com - Investing.com South Africa

Feb 10, 2026
pulisher
Feb 09, 2026

Analyst Reiterates Bullish Stance on Edgewise Stock - Intellectia AI

Feb 09, 2026
pulisher
Feb 09, 2026

Why Edgewise Therapeutics Stock Crushed the Market on Monday - AOL.com

Feb 09, 2026
pulisher
Feb 09, 2026

Edgewise Therapeutics (NASDAQ:EWTX) Sets New 12-Month HighTime to Buy? - MarketBeat

Feb 09, 2026
pulisher
Feb 09, 2026

Why Edgewise Therapeutics Stock Crushed the Market on Monday - The Motley Fool

Feb 09, 2026
pulisher
Feb 09, 2026

Piper Sandler reiterates Overweight rating on Edgewise Therapeutics stock By Investing.com - Investing.com Canada

Feb 09, 2026
pulisher
Feb 09, 2026

Piper Sandler reiterates Overweight rating on Edgewise Therapeutics stock - Investing.com

Feb 09, 2026
pulisher
Feb 07, 2026

Federated Hermes Inc. Decreases Stock Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat

Feb 07, 2026
pulisher
Feb 07, 2026

Edgewise Therapeutics (NASDAQ:EWTX) Downgraded by Wall Street Zen to Sell - Defense World

Feb 07, 2026
pulisher
Feb 05, 2026

Growth Recap: Can Edgewise Therapeutics Inc expand its profit margins2025 Earnings Impact & Weekly Stock Breakout Alerts - baoquankhu1.vn

Feb 05, 2026
pulisher
Feb 05, 2026

Edgewise Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 12, 2026 - 富途牛牛

Feb 05, 2026
pulisher
Feb 05, 2026

Braveheart Bio names Marc Evanchik CSO - The Pharma Letter

Feb 05, 2026
pulisher
Feb 03, 2026

Edgewise Therapeutics (EWTX): Analyst Consensus Reveals A 32% Upside Potential - DirectorsTalk Interviews

Feb 03, 2026
pulisher
Feb 03, 2026

Dow Update: What analysts say about Edgewise Therapeutics Inc stockJuly 2025 Review & AI Enhanced Execution Alerts - baoquankhu1.vn

Feb 03, 2026
pulisher
Feb 03, 2026

Edgewise Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules - 富途牛牛

Feb 03, 2026
pulisher
Feb 02, 2026

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Short Interest Down 19.4% in January - MarketBeat

Feb 02, 2026
pulisher
Feb 02, 2026

Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - PR Newswire

Feb 02, 2026
pulisher
Feb 02, 2026

Y Intercept Hong Kong Ltd Invests $929,000 in Edgewise Therapeutics, Inc. $EWTX - MarketBeat

Feb 02, 2026
pulisher
Feb 02, 2026

Responsive Playbooks and the EWTX Inflection - Stock Traders Daily

Feb 02, 2026
pulisher
Feb 01, 2026

EPS Watch: Is Edgewise Therapeutics Inc exposed to currency risksRisk Management & Low Risk Growth Stock Ideas - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 31, 2026

Returns Recap: Will Edgewise Therapeutics Inc benefit from current market trendsWeekly Risk Summary & Real-Time Stock Price Movement Reports - baoquankhu1.vn

Jan 31, 2026
pulisher
Jan 27, 2026

Edgewise Therapeutics Reports Q3 2025 Financial Results - MSN

Jan 27, 2026
pulisher
Jan 25, 2026

Campbell & CO Investment Adviser LLC Lowers Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat

Jan 25, 2026
pulisher
Jan 24, 2026

Edgewise Therapeutics director sells $3.39 million in shares By Investing.com - Investing.com India

Jan 24, 2026
pulisher
Jan 24, 2026

Edgewise Therapeutics(EWTX.US) Director Sells US$3.4 Million in Common Stock - 富途牛牛

Jan 24, 2026
pulisher
Jan 24, 2026

Retail Trends: Will Edgewise Therapeutics Inc stock hit new highs in YEAR2025 Market WrapUp & Fast Gain Swing Trade Alerts - baoquankhu1.vn

Jan 24, 2026
pulisher
Jan 24, 2026

Wall Street Zen Upgrades Edgewise Therapeutics (NASDAQ:EWTX) to "Hold" - MarketBeat

Jan 24, 2026
pulisher
Jan 23, 2026

Insider Sell: Badreddin Edris Sells 115,471 Shares of Edgewise Therapeutics Inc (EWTX) - GuruFocus

Jan 23, 2026
pulisher
Jan 23, 2026

Edgewise Therapeutics (NASDAQ:EWTX) Director Sells $3,399,466.24 in Stock - MarketBeat

Jan 23, 2026
pulisher
Jan 23, 2026

Edgewise Therapeutics director sells $3.39 million in shares - Investing.com

Jan 23, 2026
pulisher
Jan 22, 2026

Retail Trends: Is Edgewise Therapeutics Inc trading at a discountJuly 2025 Institutional & Real-Time Volume Triggers - baoquankhu1.vn

Jan 22, 2026
pulisher
Jan 22, 2026

Understanding the Setup: (EWTX) and Scalable Risk - Stock Traders Daily

Jan 22, 2026
pulisher
Jan 21, 2026

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat

Jan 21, 2026
pulisher
Jan 20, 2026

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: A 39% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Jan 20, 2026
pulisher
Jan 18, 2026

Edgewise Therapeutics, Inc. (EWTX) outlines priorities for 2026 - MSN

Jan 18, 2026
pulisher
Jan 17, 2026

Is Edgewise Therapeutics (EWTX) Quietly Redefining Its Risk Profile With an Integrated Muscle-Heart Strategy? - Sahm

Jan 17, 2026
pulisher
Jan 17, 2026

Medpace and Edgewise Therapeutics Advance Becker Muscular Dystrophy Study - MSN

Jan 17, 2026
pulisher
Jan 15, 2026

Edgewise Therapeutics (NASDAQ:EWTX) Shares Down 6.4%Time to Sell? - MarketBeat

Jan 15, 2026
pulisher
Jan 15, 2026

Edgewise Therapeutics, Inc. (EWTX) Outlines Priorities For 2026 - Insider Monkey

Jan 15, 2026
$26.45
price down icon 1.12%
$45.19
price up icon 0.87%
$101.10
price up icon 0.35%
$105.87
price up icon 0.10%
$148.75
price up icon 1.77%
biotechnology ONC
$346.07
price down icon 0.10%
Kapitalisierung:     |  Volumen (24h):